CHRISTIAN REYNES: Open Payments
NPI 1952956708 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,179 in 56 payments from 21 companies in 2025. Trend: 2023 $1,502 · 2024 $1,471 · 2025 $1,179
Food & beverage: $1,179
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $160 |
| Insmed, Inc. | 4 | $127 |
| Exact Sciences Corporation | 4 | $117 |
| Amgen Inc. | 5 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Astellas Pharma US Inc | 4 | $79 |
| PFIZER INC. | 4 | $73 |
| ABBVIE INC. | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
Products named: Arikayce, Ozempic, OTEZLA, CAPLYTA, Veozah, VRAYLAR, The Cologuard Plus Collection Kit, Cologuard Collection Kit.
Industry payments across FL — which companies pay providers there.
